Cargando…

Risk Factors and Psychological Analysis of Chronic Immune Thrombocytopenia in Children

OBJECTIVE: To study the risk factors and psychological changes in children with chronic immune thrombocytopenia (CITP). METHODS: This was a retrospective analysis of 234 children with ITP diagnosed and treated in the Affiliated Hospital of Southwest Medical University from January 2016 to December 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Ying, Long, Sili, Liu, Wenjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779312/ https://www.ncbi.nlm.nih.gov/pubmed/33408505 http://dx.doi.org/10.2147/IJGM.S290459

Ejemplares similares

Observation of the molecular genetics among children with acute lymphoblastic leukemia: A retrospective study based on the SEER database
por: Sun, Ying, et al.
Publicado: (2020)

Spotlight on eltrombopag in the treatment of children with chronic immune thrombocytopenia
por: Lambert, Michele P
Publicado: (2016)

Eltrombopag Effectiveness and Tolerability in Chronic Immune Thrombocytopenia: A Meta-Analysis
por: Ahmed, Hafiz Abdul Waqas, et al.
Publicado: (2021)

Health-related quality of life in children with chronic immune thrombocytopenia in China
por: Zhang, Heng, et al.
Publicado: (2016)

PB2623: AVATROMBOPAG FOR THE TREATMENT OF CHILDREN WITH PERSISTENT AND CHRONIC IMMUNE THROMBOCYTOPENIA
por: An, Qi, et al.
Publicado: (2023)

Acute on Chronic Immune Thrombocytopenia as a Cause of Thrombocytopenia in Sepsis
por: Kudaravalli, Pujitha, et al.
Publicado: (2020)

Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease
por: Cheloff, Abraham Z, et al.
Publicado: (2019)

Chronic Refractory Immune Thrombocytopenia Is Associated With Variants in Immune Genes
por: Zhao, Shasha, et al.
Publicado: (2021)

High Remission Rate of Chronic Immune Thrombocytopenia in Children: Result of 20-Year Follow-Up
por: Kim, Chae Young, et al.
Publicado: (2016)

Cost Effectiveness of Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in Ireland
por: Lee, Dawn, et al.
Publicado: (2013)

Efficacy and safety of thrombopoietin receptor agonists in children with chronic immune thrombocytopenia: a meta-analysis
por: Guo, Jian-Chun, et al.
Publicado: (2017)

Prognostic Factors for Immune Thrombocytopenia Outcome in Greek Children: A Retrospective Single-Centered Analysis
por: Makis, Alexandros, et al.
Publicado: (2017)

Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival
por: Haddad, Tyler C., et al.
Publicado: (2021)

Regulatory T-lymphocyte subsets in children with chronic immune thrombocytopenia after high-dose of dexamethasone
por: Elsayh, Khalid Ibrahim, et al.
Publicado: (2022)

Hemostatic challenges in patients with chronic immune thrombocytopenia treated with eltrombopag
por: Tarantino, Michael D., et al.
Publicado: (2014)

Risk factors of significant relapse and appropriate maintenance therapy strategy in SLE-associated immune thrombocytopenia
por: Li, He-Jun, et al.
Publicado: (2023)

Helicobacter pylori Infection and Chronic Immune Thrombocytopenia
por: Takeuchi, Hiroaki, et al.
Publicado: (2022)

Rituximab for Children with Immune Thrombocytopenia: A Systematic Review
por: Liang, Yi, et al.
Publicado: (2012)

Immune thrombocytopenia: serum cytokine levels in children and adults
por: Čulić, Srđana, et al.
Publicado: (2013)

Long-Term Use of the Thrombopoietin-Mimetic Romiplostim in Children With Severe Chronic Immune Thrombocytopenia (ITP)
por: Bussel, James B, et al.
Publicado: (2015)

Clinical Manifestations and Risk Factors of Tigecycline-Associated Thrombocytopenia
por: Zhu, Yuanchao, et al.
Publicado: (2023)

AZD-1222/tozinameran: Immune thrombocytopenia and exacerbation of pre-existing chronic immune thrombocytopenia: 4 case reports
Publicado: (2022)

Patient-reported treatment burden of chronic immune thrombocytopenia therapies
por: Brown, T Michelle, et al.
Publicado: (2012)

Immune thrombocytopenia
Publicado: (2011)

Cost-minimization analysis comparing eltrombopag vs romiplostim for adults with chronic immune thrombocytopenia
por: Patwardhan, Pallavi, et al.
Publicado: (2021)

Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation
por: Qu, Mingming, et al.
Publicado: (2018)

A Saudi Child With Chronic Immune Thrombocytopenia and Vitiligo
por: Alhebshi, Abdulqader, et al.
Publicado: (2020)

Regulatory and Memory B Lymphocytes in Children With Newly Diagnosed Immune Thrombocytopenia
por: Zahran, Asmaa M., et al.
Publicado: (2017)

Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopenia
por: Tremblay, Gabriel, et al.
Publicado: (2018)

Seroprevalence of severe fever with thrombocytopenia syndrome virus in southeastern China and analysis of risk factors
por: SUN, J. M., et al.
Publicado: (2015)

Efficacy and Safety of Avatrombopag in Patients with Chronic Immune Thrombocytopenia: A Systematic Literature Review and Network Meta-Analysis
por: Wojciechowski, Piotr, et al.
Publicado: (2021)

Risk Factors and Clinical Characteristics of Severe Fever with Thrombocytopenia Syndrome
por: Wang, Fei, et al.
Publicado: (2020)

Risk factors and prognosis of thrombocytopenia in people living with HIV/AIDS
por: Lv, Xiaoyan, et al.
Publicado: (2023)

Covid-19 and Children with Immune Thrombocytopenia: Emerging Issues
por: Lassandro, Giuseppe, et al.
Publicado: (2020)

Response to rituximab in children and adults with immune thrombocytopenia (ITP)
por: Harris, Emily M., et al.
Publicado: (2021)

Association of Immune Thrombocytopenia and Inflammatory Bowel Disease in Children
por: Guarina, Angela, et al.
Publicado: (2021)

Spotlight on romiplostim in the treatment of children with chronic immune thrombocytopenia: design, development, and potential place in therapy
por: Buchbinder, David, et al.
Publicado: (2017)

Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopenia
por: Tarantino, Michael D., et al.
Publicado: (2019)

Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib
por: Cooper, Nichola, et al.
Publicado: (2021)

Efficacy and safety of a new intravenous immunoglobulin (Panzyga(®)) in chronic immune thrombocytopenia
por: Arbach, O., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5i17f4qe4elvuamblpodvpmjfr